SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001144204-15-046719
Filing Date
2015-08-06
Accepted
2015-08-06 08:30:19
Documents
1
Period of Report
2015-07-22

Document Format Files

Seq Description Document Type Size
1 AMENDMENT TO FORM 4 v417301_4a.html 4/A  
1 AMENDMENT TO FORM 4 v417301_4a.xml 4/A 4572
  Complete submission text file 0001144204-15-046719.txt   6125
Mailing Address C/O MEDGENICS, INC. 435 DEVON PARK DRIVE, BLDG 700 WAYNE PA 19087
Business Address C/O MEDGENICS, INC. 435 DEVON PARK DRIVE, BLDG 700 WAYNE PA 19087 610-254-4201
MEDGENICS, INC. (Issuer) CIK: 0001138776 (see all company filings)

IRS No.: 980217544 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O INTERCEPT PHARMACEUTICALS, INC. 18 DESBROSSES STREET NEW YORK NY 10013
Business Address
Duncan Barbara Gayle (Reporting) CIK: 0001353128 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-35112 | Film No.: 151031236